High Throughput Screening Market

High Throughput Screening Market by Product (Instrument, Consumable, Service), Technology (Cell-based Assays, Lab-on-a-Chip, Label-free), Application (Drug Discovery, Life Sciences Research), End User (Pharma, Biotech, CRO) - Global Forecast to 2028

Report Code: BT 2220 Jul, 2023, by marketsandmarkets.com

The global high throughput screening market in terms of revenue was estimated to be worth $25.7 billion in 2023 and is poised to reach $44.5 billion by 2028, growing at a CAGR of 11.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by growing adoption of high-throughput screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research. On the other hand, the high cost of high-throughput screening systems is restraining the growth of this market.

High-Throughput Screening (HTS) Market- Global Forecast to 2028

High-Throughput Screening (HTS) Market

To know about the assumptions considered for the study, Request for Free Sample Report

High-Throughput Screening (HTS) Market

High Throughput Screening Market

DRIVER: The growing adoption of open innovative models in pharmaceutical & biotechnology companies

Open innovation refers to the practice of leveraging external ideas, technologies, and collaborations to accelerate innovation and overcome research and development challenges. Open innovation models enable pharmaceutical and biotech companies to collaborate with academic institutions, research organizations, and technology providers. This collaboration allows companies to tap into external expertise and gain access to novel technologies and approaches in HTS. By leveraging a broader knowledge base, companies can enhance their screening capabilities and improve the efficiency of drug discovery processes. Overall, the adoption of open innovative models in the pharmaceutical and biotech industries can drive the HTS market by providing access to external expertise, accelerating drug discovery, expanding compound libraries, sharing costs and risks, facilitating cross-disciplinary collaboration, and enabling access to new technologies.

RESTRAINT: The capital-intensive nature of HTS instruments

HTS instruments, such as automated liquid handling systems, robotic arms, microplate readers, and high-resolution imaging systems, require significant upfront investment. The cost of acquiring and setting up these instruments can be substantial, making it a barrier for smaller research organizations, academic institutions, and startups with limited budgets. The high initial investment can limit access to HTS technologies and slow down their adoption. In addition to the initial investment, HTS instruments often entail ongoing operational costs. These costs include maintenance, calibration, supplies, reagents, and consumables required for the screening process. These expenses can accumulate over time, and organizations need to allocate resources to cover them.

OPPORTUNITY: Increasing adoption of high-throughput screening technologies in emerging markets

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Additionally, government initiatives in emerging markets play a crucial role in promoting the adoption and development of HTS technologies. Governments can establish regulatory frameworks and guidelines to ensure the safe and ethical use of HTS technologies.

CHALLENGE: Complexity in data analysis and management

With the enormous amount of data generated from HTS experiments, there is a need for robust data management systems to handle data storage, organization, and retrieval. Additionally, data integration from various sources, such as chemical databases or genomic data, requires standardized formats and interoperability. Data quality control is crucial to ensure the reliability and accuracy of HTS data, requiring validation and normalization procedures.

Global High-Throughput Screening (HTS) Ecosystem Analysis

The ecosystem for HTS consists of pharmaceutical & biotechnology companies, HTS service providers (screening services), instrument & reagent suppliers, academic & research institutions, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of HTS technologies, enhance drug discovery processes, and develop new therapeutics.

High-Throughput Screening (HTS) Market Ecosystem

The consumables segment dominated high throughput screening industry by product & service:

Based on product & service, the high throughput screening market is segmented into consumables, instruments, services, and software. The consumables segment accounted for the largest share of the global market in 2022. This segment's large share can be attributed to factors such as wide used of reagents & assay kits used in HTS techniques, increasing pharmaceutical R&D, and increasing government funding for life sciences research.

High-Throughput Screening (HTS) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Asia Pacific region catered the fastest growth of the high throughput screening industry in 2022.

In 2022, Asia Pacific region accounted for the fastest-growing region of the high throughput screening market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, rising prevalence of chronic diseases and the need for effective disease monitoring and drug development and the growing trend of outsourcing drug discovery services.

Key Market Players

Key players in the high throughput screening market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).

Scope of the High Throughput Screening Industry

Report Metric 

Details 

Market Revenue un 2023

$25.7 billion

Projected Revenue by 2028

$44.5 billion

Revenue Rate

Poised to Grow at a CAGR of 11.6%

Market Driver

The growing adoption of open innovative models in pharmaceutical & biotechnology companies

Market Opportunity

Increasing adoption of high-throughput screening technologies in emerging markets

This report categorizes the high throughput screening market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

  • Consumables
    • Reagents & Assay Kits
    • Laboratory Equipment
  • Instruments
    • Liquid Handling Systems
    • Detection Systems
    • Other Instruments
  • Services
  • Software

By Technology

  • Cell-based Assays
    • 2D Cell Culture
    • 3D Cell Culture
      • Scaffold-based Technology
        • Hydrogels
          • Animal-derived Hydrogels
            • Matrigel
            • Collagen
          • Synthetic Hydrogels
          • Alginate/Agarose
        • Inert Matrix/Solid Scaffolds
        • Micropatterned Surfaces
      • Scaffold-free Technology
        • Ultra-low Binding Plates
        • Hanging-drop Plates
        • Other Scaffold-free Technologies
    • Reporter-based Assays
    • Perfusion Cell Culture
  • Lab-on-a-Chip Technology (LOC)
  • Label-free Technology

By Application

  • Drug Discovery
  • Biochemical Screening
  • Life Sciences Research
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments of High Throughput Screening Industry

  • In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler that integrates with the Agilent Bravo NGS automated liquid handling platform.
  • In February 2023, PerkinElmer Inc. launched the Multimode Plate Reader for high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 50)
    1.1 STUDY OBJECTIVES 
    1.2 HIGH THROUGHPUT SCREENING INDUSTRY DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 HTS MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
           1.3.2 CURRENCY CONSIDERED
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 55)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 HTS MARKET: BREAKDOWN OF PRIMARIES
    2.2 HIGH THROUGHPUT SCREENING MARKET SIZE ESTIMATION 
          FIGURE 4 HIGH THROUGHPUT SCREENING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
          FIGURE 5 HIGH THROUGHPUT SCREENING MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
          FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE SHARE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
                    FIGURE 8 HIGH THROUGHPUT SCREENING MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH FORECAST 
          FIGURE 9 HTS MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 10 HTS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 67)
    FIGURE 12 HIGH THROUGHPUT SCREENING MARKET PREDICTION, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 HIGH THROUGHPUT SCREENING INDUSTRY, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 HIGH THROUGHPUT SCREENING INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT: HIGH THROUGHPUT SCREENING INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 71)
    4.1 HIGH THROUGHPUT SCREENING MARKET OVERVIEW 
          FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: HIGH THROUGHPUT SCREENING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 
          FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN HTS MARKET IN 2022
    4.3 HIGH THROUGHPUT SCREENING MARKET FORECAST, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2028
    4.4 HIGH THROUGHPUT SCREENING MARKET SHARE,  BY END USER, 2022 
          FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR  LARGEST MARKET SHARE IN 2022
    4.5 HIGH THROUGHPUT SCREENING MARKET FORECAST: GEOGRAPHIC  GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 75)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 HIGH THROUGHPUT SCREENING MARKET FORECAST: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 HTS MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies
                    5.2.1.2 Government funding and venture capital investments
                                TABLE 5 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
                    5.2.1.3 Increasing R&D spending
                                FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
                    5.2.1.4 Technological advancements
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of using screening instruments
                                TABLE 6 INSTRUMENT PRICING (USD)
                    5.2.2.2 Complexities in assay development
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing adoption of screening technologies in emerging economies
                    5.2.3.2 Growing applications in stem cell research
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled operators
                    5.2.4.2 Complexities in data analysis and management
    5.3 TECHNOLOGY ANALYSIS 
          TABLE 7 TECHNOLOGY ANALYSIS
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HTS SOLUTIONS PROVIDERS
    5.5 PRICING ANALYSIS 
           5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS (GLOBAL)
                    TABLE 8 AVERAGE SELLING PRICES
           5.5.2 AVERAGE SELLING PRICE TREND
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 25 MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
    5.7 SUPPLY CHAIN ANALYSIS 
          FIGURE 26 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.8 ECOSYSTEM ANALYSIS 
          FIGURE 27 ECOSYSTEM ANALYSIS: HTS MARKET
          TABLE 9 OVERALL MARKET ECOSYSTEM FOR HTS
    5.9 PATENT ANALYSIS 
          FIGURE 28 HTS MARKET: PATENT GRANTED (JANUARY 2013–MAY 2023)
    5.10 REGULATORY ANALYSIS 
           5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
    5.11 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 14 HTS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 THREAT OF NEW ENTRANTS
           5.11.2 THREAT OF SUBSTITUTES
           5.11.3 BARGAINING POWER OF BUYERS
           5.11.4 BARGAINING POWER OF SUPPLIERS
           5.11.5 INTENSITY OF COMPETITIVE RIVALRY
    5.12 KEY CONFERENCES & EVENTS IN 2022–2023 
           TABLE 15 HTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HTS TECHNOLOGIES
           5.13.2 BUYING CRITERIA FOR DRUG DISCOVERY SERVICES
                     FIGURE 30 KEY BUYING CRITERIA FOR END USERS
 
6 HIGH THROUGHPUT SCREENING MARKET FORECAST, BY PRODUCT & SERVICE (Page No. - 100)
    6.1 INTRODUCTION 
          TABLE 16 HIGH THROUGHPUT SCREENING INDUSTRY, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 CONSUMABLES 
          TABLE 17 HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 18 HTS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 19 NORTH AMERICA: HTS CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 20 EUROPE: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 21 ASIA PACIFIC: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 22 LATIN AMERICA: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 REAGENTS & ASSAY KITS
                    6.2.1.1 Wide applications in life sciences research to support demand for consumables
                                TABLE 23 HTS REAGENTS & ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 24 NORTH AMERICA: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 25 EUROPE: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 26 ASIA PACIFIC: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 27 LATIN AMERICA: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.2 LABORATORY EQUIPMENT
                    6.2.2.1 Development of high-quality equipment to drive market
                                TABLE 28 HTS LABORATORY EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 29 NORTH AMERICA: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 30 EUROPE: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 31 ASIA PACIFIC: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 32 LATIN AMERICA: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    6.3 INSTRUMENTS 
          TABLE 33 HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 34 HTS INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 35 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 36 EUROPE: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 37 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 38 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 LIQUID HANDLING SYSTEMS
                    6.3.1.1 Increased innovation and automation to drive market
                                TABLE 39 HTS LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 40 NORTH AMERICA: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 41 EUROPE: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 42 ASIA PACIFIC: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 43 LATIN AMERICA: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.2 DETECTION SYSTEMS
                    6.3.2.1 Demand for high-throughput capabilities to support growth
                                TABLE 44 HTS DETECTION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 45 NORTH AMERICA: HTS DETECTION SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 46 EUROPE: HTS DETECTION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 47 ASIA PACIFIC: HTS DETECTION SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 48 LATIN AMERICA: HTS DETECTION SYSTEMS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.3 OTHER INSTRUMENTS
                    TABLE 49 HTS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 50 NORTH AMERICA: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 51 EUROPE: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 52 ASIA PACIFIC: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 53 LATIN AMERICA: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY,  2021–2028 (USD MILLION)
    6.4 SERVICES 
           6.4.1 NEED FOR COST OPTIMIZATION AND ACCESS TO SPECIALIZED EXPERTISE TO BOOST DEMAND
                    TABLE 54 HTS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 55 NORTH AMERICA: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 56 EUROPE: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 57 ASIA PACIFIC: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 LATIN AMERICA: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 SOFTWARE 
           6.5.1 RISING AUTOMATION AND AVAILABILITY OF ROBUST DATA MANAGEMENT SOFTWARE TOOLS TO DRIVE MARKET
                    TABLE 59 HTS SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 60 NORTH AMERICA: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 61 EUROPE: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 ASIA PACIFIC: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 LATIN AMERICA: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 HIGH THROUGHPUT SCREENING MARKET FORECAST, BY TECHNOLOGY (Page No. - 122)
    7.1 INTRODUCTION 
          TABLE 64 HIGH THROUGHPUT SCREENING INDUSTRY, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    7.2 CELL-BASED ASSAYS 
          TABLE 65 COMPARISON OF 2D AND 3D CELL CULTURE
          TABLE 66 HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 67 HTS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 68 NORTH AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 69 EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 70 ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 71 LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
           7.2.1 2D CELL CULTURE
                    TABLE 72 HTS MARKET FOR 2D CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 73 NORTH AMERICA: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 74 EUROPE: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 75 ASIA PACIFIC: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 76 LATIN AMERICA: HTS MARKET FOR 2D CELL CULTURE BY COUNTRY,  2021–2028 (USD MILLION)
           7.2.2 3D CELL CULTURE
                    TABLE 77 HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 78 HTS MARKET FOR 3D CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 79 NORTH AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 80 EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 81 ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 82 LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    7.2.2.1 Scaffold-based technology
                                TABLE 83 HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 84 HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 85 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 86 EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 87 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 88 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                               7.2.2.1.1 Hydrogels
                                              TABLE 89 HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                              TABLE 90 HTS MARKET FOR HYDROGELS, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 91 NORTH AMERICA: HTS MARKET FOR HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 92 EUROPE: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 93 ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 94 LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                             7.2.2.1.1.1 Animal-derived hydrogels
                                                              TABLE 95 HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                                              TABLE 96 HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION,  2021–2028 (USD MILLION)
                                                              TABLE 97 NORTH AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 98 EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 99 ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 100 LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                               7.2.2.1.1.1.1 Matrigel
                                                                                  TABLE 101 HTS MARKET FOR MATRIGEL, BY REGION, 2021–2028 (USD MILLION)
                                                                                  TABLE 102 NORTH AMERICA: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION)
                                                                                  TABLE 103 EUROPE: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION)
                                                                                  TABLE 104 ASIA PACIFIC: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION)
                                                                                  TABLE 105 LATIN AMERICA: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION)
                                                               7.2.2.1.1.1.2 Collagen
                                                                                  TABLE 106 HTS MARKET FOR COLLAGEN, BY REGION, 2021–2028 (USD MILLION)
                                                                                  TABLE 107 NORTH AMERICA: HTS MARKET FOR COLLAGEN, BY COUNTRY,  2021–2028 (USD MILLION)
                                                                                  TABLE 108 EUROPE: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION)
                                                                                  TABLE 109 ASIA PACIFIC: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION)
                                                                                  TABLE 110 LATIN AMERICA: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION)
                                             7.2.2.1.1.2 Synthetic hydrogels
                                                              TABLE 111 HTS MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2021–2028 (USD MILLION)
                                                              TABLE 112 NORTH AMERICA: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 113 EUROPE: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 114 ASIA PACIFIC: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 115 LATIN AMERICA: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY,  2021–2028 (USD MILLION)
                                             7.2.2.1.1.3 Alginate/Agarose
                                                              TABLE 116 HTS MARKET FOR ALGINATE/AGAROSE, BY REGION, 2021–2028 (USD MILLION)
                                                              TABLE 117 NORTH AMERICA: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 118 EUROPE: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 119 ASIA PACIFIC: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY,  2021–2028 (USD MILLION)
                                                              TABLE 120 LATIN AMERICA: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY,  2021–2028 (USD MILLION)
                               7.2.2.1.2 Inert matrix/Solid scaffolds
                                              TABLE 121 HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY REGION,  2021–2028 (USD MILLION)
                                              TABLE 122 NORTH AMERICA: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 123 EUROPE: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 124 ASIA PACIFIC: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 125 LATIN AMERICA: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2021–2028 (USD MILLION)
                               7.2.2.1.3 Micropatterned surfaces
                                              TABLE 126 HTS MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 127 NORTH AMERICA: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 128 EUROPE: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 129 ASIA PACIFIC: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 130 LATIN AMERICA: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY,  2021–2028 (USD MILLION)
                    7.2.2.2 Scaffold-free technology
                                TABLE 131 HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 132 HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 133 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 134 EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 135 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 136 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
                               7.2.2.2.1 Ultra-low binding plates
                                              TABLE 137 HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 138 NORTH AMERICA: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 139 EUROPE: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 140 ASIA PACIFIC: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 141 LATIN AMERICA: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                               7.2.2.2.2 Hanging-drop plates
                                              TABLE 142 HTS MARKET FOR HANGING-DROP PLATES, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 143 NORTH AMERICA: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 144 EUROPE: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 145 ASIA PACIFIC: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                                              TABLE 146 LATIN AMERICA: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY,  2021–2028 (USD MILLION)
                               7.2.2.2.3 Other scaffold-free technologies
                                              TABLE 147 HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION,  2021–2028 (USD MILLION)
                                              TABLE 148 NORTH AMERICA: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 149 EUROPE: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 150 ASIA PACIFIC: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 151 LATIN AMERICA: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.3 REPORTER-BASED ASSAYS
                    TABLE 152 HTS MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 153 NORTH AMERICA: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 154 EUROPE: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 155 ASIA PACIFIC: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 156 LATIN AMERICA: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY,  2021–2028 (USD MILLION)
           7.2.4 PERFUSION CELL CULTURE
                    TABLE 157 HTS MARKET FOR PERFUSION CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 158 NORTH AMERICA: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 159 EUROPE: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 160 ASIA PACIFIC: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 161 LATIN AMERICA: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
    7.3 LAB-ON-A-CHIP TECHNOLOGY 
          TABLE 162 HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
          TABLE 163 NORTH AMERICA: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 164 EUROPE: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 165 ASIA PACIFIC: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 166 LATIN AMERICA: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
    7.4 LABEL-FREE TECHNOLOGY 
          TABLE 167 HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
          TABLE 168 NORTH AMERICA: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 169 EUROPE: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 170 ASIA PACIFIC: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 171 LATIN AMERICA: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY,  2021–2028 (USD MILLION)
 
8 HIGH THROUGHPUT SCREENING MARKET TRENDS, BY APPLICATION (Page No. - 168)
    8.1 INTRODUCTION 
          TABLE 172 HIGH THROUGHPUT SCREENING INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 DRUG DISCOVERY 
           8.2.1 DEMAND FOR EFFICIENT AND EFFECTIVE METHODS TO IDENTIFY AND DEVELOP DRUG CANDIDATES TO DRIVE MARKET
                    TABLE 173 HTS MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 174 NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 175 EUROPE: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 176 ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 177 LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2021–2028 (USD MILLION)
    8.3 BIOCHEMICAL SCREENING 
           8.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO DRIVE MARKET
                    TABLE 178 HTS MARKET FOR BIOCHEMICAL SCREENING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 179 NORTH AMERICA: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 180 EUROPE: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 181 ASIA PACIFIC: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 182 LATIN AMERICA: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY,  2021–2028 (USD MILLION)
    8.4 LIFE SCIENCES RESEARCH 
           8.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH AND STUDY OF INFECTIOUS DISEASES TO DRIVE MARKET
                    TABLE 183 HTS MARKET FOR LIFE SCIENCES RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 184 NORTH AMERICA: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 185 EUROPE: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 186 ASIA PACIFIC: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 187 LATIN AMERICA: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY,  2021–2028 (USD MILLION)
    8.5 OTHER APPLICATIONS 
          TABLE 188 HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 189 NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 190 EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 191 ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 192 LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
 
9 HIGH THROUGHPUT SCREENING MARKET TRENDS, BY END USER (Page No. - 179)
    9.1 INTRODUCTION 
          TABLE 193 HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.2.1 DEMAND FOR MINIATURIZED SCREENING SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH
                    TABLE 194 HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 195 NORTH AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 196 EUROPE: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 197 ASIA PACIFIC: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 198 LATIN AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 ACADEMIC & RESEARCH INSTITUTES 
           9.3.1 ADOPTION OF HIGH-THROUGHPUT SCREENING IN COLLABORATIVE RESEARCH TO DRIVE MARKET
                    TABLE 199 HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 200 NORTH AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 201 EUROPE: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 202 ASIA PACIFIC: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 203 LATIN AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 CONTRACT RESEARCH ORGANIZATIONS 
           9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET
                    TABLE 204 HTS MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 205 NORTH AMERICA: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 206 EUROPE: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 207 ASIA PACIFIC: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 208 LATIN AMERICA: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 OTHER END USERS 
          TABLE 209 HTS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 210 NORTH AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 211 EUROPE: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 212 ASIA PACIFIC: HTS MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 213 LATIN AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)
 
10 HIGH THROUGHPUT SCREENING MARKET TRENDS, BY REGION (Page No. - 190)
     10.1 INTRODUCTION 
             TABLE 214 HIGH THROUGHPUT SCREENING INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 31 NORTH AMERICA: HIGH THROUGHPUT SCREENING MARKET SNAPSHOT
                        TABLE 215 NORTH AMERICA: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 216 NORTH AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 217 NORTH AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 218 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 219 NORTH AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 220 NORTH AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 221 NORTH AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 222 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 223 NORTH AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 224 NORTH AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 225 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 226 NORTH AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 227 NORTH AMERICA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 US
                        10.2.2.1 US to dominate market in North America
                                      TABLE 228 US: HIGH THROUGHPUT SCREENING MARKET TRENDS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 229 US: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 230 US: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 US: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 232 US: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 233 US: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 234 US: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 235 US: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 236 US: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 237 US: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 238 US: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 239 US: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Government initiatives to promote research and support market growth
                                      TABLE 240 CANADA: HIGH THROUGHPUT SCREENING MARKET TRENDS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 241 CANADA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 242 CANADA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 243 CANADA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 244 CANADA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 245 CANADA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 246 CANADA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 247 CANADA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 CANADA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 249 CANADA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 250 CANADA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 251 CANADA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                        TABLE 252 EUROPE: HIGH THROUGHPUT SCREENING , BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 253 EUROPE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 254 EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 255 EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 256 EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 257 EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 258 EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 259 EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 260 EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 261 EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 262 EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 263 EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 264 EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Increasing research activity to favor demand for screening solutions
                                      TABLE 265 GERMANY: HIGH THROUGHPUT SCREENING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 266 GERMANY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 267 GERMANY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 268 GERMANY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 269 GERMANY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 270 GERMANY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 271 GERMANY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 272 GERMANY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 273 GERMANY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 274 GERMANY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 275 GERMANY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 276 GERMANY: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to support market
                                      FIGURE 32 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
                                      TABLE 277 UK: HIGH THROUGHPUT SCREENING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 278 UK: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 279 UK: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 280 UK: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 281 UK: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 282 UK: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 283 UK: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 284 UK: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 285 UK: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 286 UK: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 287 UK: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 288 UK: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Large pharmaceutical manufacturing industry to drive market
                                      TABLE 289 FRANCE: HIGH THROUGHPUT SCREENING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 290 FRANCE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 291 FRANCE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 292 FRANCE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 293 FRANCE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 294 FRANCE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 295 FRANCE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 296 FRANCE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 297 FRANCE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 298 FRANCE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 299 FRANCE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 300 FRANCE: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Strong collaborative research networks to fuel growth
                                      TABLE 301 ITALY: HIGH THROUGHPUT SCREENING MARKET OVERVIEW, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 302 ITALY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 303 ITALY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 304 ITALY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 305 ITALY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 306 ITALY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 307 ITALY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 308 ITALY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 309 ITALY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 310 ITALY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 311 ITALY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 312 ITALY: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to drive market
                                      TABLE 313 SPAIN: HIGH THROUGHPUT SCREENING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 314 SPAIN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 315 SPAIN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 316 SPAIN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 317 SPAIN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 318 SPAIN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 319 SPAIN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 320 SPAIN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 321 SPAIN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 322 SPAIN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 323 SPAIN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 324 SPAIN: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 325 REST OF EUROPE: HIGH THROUGHPUT SCREENING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 326 REST OF EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 327 REST OF EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 328 REST OF EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 329 REST OF EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 330 REST OF EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 331 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 332 REST OF EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 333 REST OF EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 334 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 335 REST OF EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 336 REST OF EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 33 ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET SNAPSHOT
                        TABLE 337 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 338 ASIA PACIFIC: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 339 ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 340 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 341 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 342 ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 343 ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 344 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 345 ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 346 ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 347 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 348 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 349 ASIA PACIFIC: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Presence of key CROs to favor market growth
                                      TABLE 350 CHINA: HIGH THROUGHPUT SCREENING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 351 CHINA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 352 CHINA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 353 CHINA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 354 CHINA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 355 CHINA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 356 CHINA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 357 CHINA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 358 CHINA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 359 CHINA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 360 CHINA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 361 CHINA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Rising prominence of regenerative medicine research to drive market
                                      TABLE 362 JAPAN: HIGH THROUGHPUT SCREENING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 363 JAPAN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 364 JAPAN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 365 JAPAN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 366 JAPAN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 367 JAPAN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 368 JAPAN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 369 JAPAN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 370 JAPAN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 371 JAPAN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 372 JAPAN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 373 JAPAN: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Low-cost services and strong government support to propel market
                                      TABLE 374 INDIA: HIGH THROUGHPUT SCREENING MARKET ANALYSIS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 375 INDIA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 376 INDIA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 377 INDIA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 378 INDIA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 379 INDIA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 380 INDIA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 381 INDIA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 382 INDIA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 383 INDIA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 384 INDIA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 385 INDIA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 386 REST OF ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET SEGMENTS, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 387 REST OF ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 388 REST OF ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 389 REST OF ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 390 REST OF ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 391 REST OF ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 392 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 393 REST OF ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 394 REST OF ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 395 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 396 REST OF ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 397 REST OF ASIA PACIFIC: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 398 LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET SEGMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 399 LATIN AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 400 LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 401 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 402 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 403 LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 404 LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 405 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 406 LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 407 LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 408 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 409 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 410 LATIN AMERICA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 BRAZIL
                        10.5.2.1 Rising research activity to contribute to growth
                                      TABLE 411 BRAZIL: HIGH THROUGHPUT SCREENING MARKET SEGMENTS, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 412 BRAZIL: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 413 BRAZIL: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 414 BRAZIL: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 415 BRAZIL: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 416 BRAZIL: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 417 BRAZIL: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 418 BRAZIL: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 419 BRAZIL: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 420 BRAZIL: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 421 BRAZIL: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 422 BRAZIL: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 423 REST OF LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET SEGMENTS, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 424 REST OF LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 425 REST OF LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 426 REST OF LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 427 REST OF LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 428 REST OF LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 429 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 430 REST OF LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 431 REST OF LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 432 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 433 REST OF LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 434 REST OF LATIN AMERICA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 435 MIDDLE EAST & AFRICA: HIGH THROUGHPUT SCREENING MARKET SEGMENTS, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 436 MIDDLE EAST & AFRICA: HTS CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 437 MIDDLE EAST & AFRICA: HTS INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 438 MIDDLE EAST & AFRICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 439 MIDDLE EAST & AFRICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 440 MIDDLE EAST & AFRICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 441 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 442 MIDDLE EAST & AFRICA: HTS MARKET FOR HYDROGELS, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 443 MIDDLE EAST & AFRICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 444 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 445 MIDDLE EAST & AFRICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 446 MIDDLE EAST & AFRICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 283)
     11.1 INTRODUCTION 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 34 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION: STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS 
             FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 447 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 37 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             TABLE 448 COMPANY FOOTPRINT ANALYSIS (KEY PLAYERS)
             TABLE 449 PRODUCT FOOTPRINT ANALYSIS (KEY PLAYERS)
             TABLE 450 REGIONAL FOOTPRINT ANALYSIS (KEY PLAYERS)
     11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
                        FIGURE 38 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 
             TABLE 451 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 452 HIGH THROUGHPUT SCREENING MARKET PREDICTION: COMPETITIVE BENCHMARKING OF START- UPS/SMES
     11.9 COMPETITIVE SCENARIOS AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 453 HIGH THROUGHPUT SCREENING MARKET PREDICTION: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023
             11.9.2 DEALS
                        TABLE 454 HIGH THROUGHPUT SCREENING MARKET PREDICTION: DEALS, JANUARY 2020–MAY 2023
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 455 HIGH THROUGHPUT SCREENING MARKET PREDICTION: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023
 
12 COMPANY PROFILES (Page No. - 299)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY COMPANIES 
             12.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 456 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 39 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             12.1.2 AGILENT TECHNOLOGIES, INC.
                        TABLE 457 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             12.1.3 MERCK KGAA
                        TABLE 458 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
             12.1.4 DANAHER CORPORATION
                        TABLE 459 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.1 PERKINELMER, INC.
                        TABLE 460 PERKINELMER, INC.: BUSINESS OVERVIEW
                        FIGURE 43 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
             12.1.2 TECAN TRADING AG
                        TABLE 461 TECAN TRADING AG: BUSINESS OVERVIEW
                        FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
             12.1.3 AXXAM S.P.A
                        TABLE 462 AXXAM S.P.A: BUSINESS OVERVIEW
             12.1.4 BIO-RAD LABORATORIES, INC.
                        TABLE 463 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             12.1.5 PROMEGA CORPORATION
                        TABLE 464 PROMEGA CORPORATION: BUSINESS OVERVIEW
             12.1.6 CORNING INCORPORATED
                        TABLE 465 CORNING INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 46 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
             12.1.7 CHARLES RIVER LABORATORIES
                        TABLE 466 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 47 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
             12.1.8 EUROFINS SCIENTIFIC
                        TABLE 467 EUROFINS SCIENTIFIC COMPANY: BUSINESS OVERVIEW
                        FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
             12.1.9 HAMILTON COMPANY
                        TABLE 468 HAMILTON COMPANY: BUSINESS OVERVIEW
             12.1.10 LONZA
                        TABLE 469 LONZA: BUSINESS OVERVIEW
                        FIGURE 49 LONZA: COMPANY SNAPSHOT (2022)
             12.1.11 REPROCELL, INC.
                        TABLE 470 REPROCELL, INC.: BUSINESS OVERVIEW
             12.1.12 AURORA BIOMED
                        TABLE 471 AURORA BIOMED: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 BMG LABTECH
             12.2.2 DIANA BIOTECHNOLOGIES S.R.O.
             12.2.3 NANOTEMPER TECHNOLOGIES GMBH
             12.2.4 CREATIVE BIOLABS
             12.2.5 BIOMAT SRL
             12.2.6 HIGHRES BIOSOLUTIONS
             12.2.7 CYCLICA, INC.
             12.2.8 CROWN BIOSCIENCE
             12.2.9 SYGNATURE DISCOVERY
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 364)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global high throughput screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global high throughput screening market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), National Institutes of Health (NIH), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Human Genome Research Institute (NHGRI). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall high throughput screening market size, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global high throughput screening market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

High-Throughput Screening (HTS) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

High Throughput Screening Market Size Estimation

The global high throughput screening market size was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the high throughput screening market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the high-throughput screening (HTS) business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

High-Throughput Screening (HTS) Market Size, and Share

Data Triangulation

After arriving at the high throughput screening market market size, from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

High-throughput screening (HTS) refers to the process of rapidly testing large numbers of compounds or samples to identify active molecules and potential drug candidates. It plays a crucial role in drug discovery, toxicology studies, and other areas of life sciences research.

Stakeholders

  • Contract research organizations
  • Pharmaceutical & biopharmaceutical companies
  • Academic & research institutes
  • HTS Instrument & Reagent Manufacturers
  • High-content Screening Database, Service, and Software Providers
  • Venture capitalists & investors
  • Market research & consulting firms
  • Government associations
  • Medical institutions & universities

Report Objectives

  • To define, describe, and forecast the global high throughput screening market based on product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the high throughput screening market size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the high throughput screening market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2220
Published ON
Jul, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the High Throughput Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback